Patents Assigned to Pacesetter, Inc.
-
Patent number: 12778429Abstract: Embodiments disclosed herein use multiple AF discriminators to determine whether to classify an AF detection as a false positive. One method includes detecting R-waves within an EGM or ECG signal, determining R-R intervals based on the R-waves, detecting AF based on the R-R intervals, and using one or more time-based AF discriminators to analyze one or more temporal features of the EGM or ECG signal within a window leading up to the AF detection to thereby determine whether to classify the AF detection as a false positive. In response to not classifying the AF detection as a false positive using the one or more time-based AF discriminators, one or more morphology-based AF discriminators are used to analyze one or more morphological features of the EGM or ECG signal within the window leading up to the AF detection to thereby determine whether to classify the AF detection as a false positive.Type: GrantFiled: August 20, 2021Date of Patent: November 3, 2026Assignee: Pacesetter, Inc.Inventors: Fujian Qu, Nima Badie, Jong Gill
-
Patent number: 12779231Abstract: While an external device is not in an active conductive communication session with one or more IMD(s), a test vector is selected and used to search for advertisement sequence(s) transmitted by the IMD(s) during an OOS search window. If the advertisement sequence(s) is/are not detected using the test vector during the OOS search window, another electrode combination is selected and used as the test vector. In response the advertisement sequence(s) being detected, an active conductive communication session is established with the IMD(s) and a respective score is determined. Then different combinations of other ones of the external electrodes are used as the test vector during an accelerated search window having a duration shorter than the OOS search window, and a respective score is determined for each of the other test vectors. Based on the scores, a preferred vector is selected and used to perform further conductive communication with the IMD(s).Type: GrantFiled: February 25, 2025Date of Patent: November 3, 2026Assignee: Pacesetter, Inc.Inventors: Thanh Tieu, Robert Williams, Yongjian Wu, Jun Yang, Mei Phelps, Arash Azarmi, Jenny Huang, Min Yang, Hussain Fatakdawala, Dulip Kaluarachchi
-
Publication number: 20260341742Abstract: A current collector for a battery includes a flexible current collector portion including a lattice defined by a plurality of interconnected unit cells, each unit cell of the plurality of interconnected unit cells including curvilinear segments bounding a through-hole, wherein an intersection of each curvilinear segment of the plurality of interconnected unit cells defines a node. One or more curvilinear segments of the plurality of interconnected unit cells define an outer border extending about an outer perimeter of the lattice and one or more control features extend radially outward from the outer border. A lead portion extends radially outward from the outer border of the lattice.Type: ApplicationFiled: April 9, 2026Publication date: October 29, 2026Applicant: Pacesetter, Inc.Inventors: Xiaofei Jiang, John Charles Duggan
-
Patent number: 12773567Abstract: Disclosed herein are implantable medical devices and systems, and methods for used therewith, that selectively perform atrial pacing at an atrial pacing rate that is faster than an intrinsic atrial rate of a patient while the patient is experiencing an atrial tachycardia or atrial fibrillation and the intrinsic atrial rate of the patient is within the specified range, to attempt to convert the arrhythmia to a normal sinus rhythm.Type: GrantFiled: December 27, 2024Date of Patent: October 27, 2026Assignee: Pacesetter, Inc.Inventor: Xing Pei
-
Patent number: 12773564Abstract: An implantable medical device (IMD) and process are provided comprising one or more electrodes configured to be implanted to define a pacing vector through at least a portion of a ventricle. Sensing circuitry is configured to sense intrinsic atrial activity (As) and intrinsic ventricular activity (Vs). A pulse generator (PG) if provided, and memory configured to store program instructions and an atrioventricular delay search parameter (AVDSEARCH). The AVDSEARCH is an interval of time. One or more processors, that when executing the program instructions, is configured to direct the PG to deliver ventricular pacing pulses based on an atrioventricular delay (AVD) and periodically initiate an AVD search operation utilizing the AVDSEARCH. A heart rate is determined and compared to a threshold. Responsive to determining that the heart rate exceeds the threshold, the AVDSEARCH is reduced, and cardiac activity is detected during the AVD search operation utilizing the reduced AVDSEARCH.Type: GrantFiled: December 18, 2023Date of Patent: October 27, 2026Assignee: Pacesetter, Inc.Inventors: Nima Badie, Aditya Goil, Kunal Chaniary
-
Patent number: 12770799Abstract: A method is provided for manufacturing an electrolytic capacitor for an implantable cardioverter defibrillator. The method includes forming an ester material by adding at least one acid to a glycol, and quenching the ester material for a determined period. The method also includes adding an ammonium based material to the ester material after the ester material is quenched, and adding an additional acid after adding the ammonium based material to form an electrolytic material for the electrolytic capacitor.Type: GrantFiled: August 15, 2023Date of Patent: October 20, 2026Assignee: Pacesetter, Inc.Inventors: R. Jason Hemphill, A. Corina Geiculescu
-
Patent number: 12752124Abstract: A medical device assembly is provided that includes a clinician programing device configured to communicate with an implanted medical device of a patient. The clinician programming device includes one or more processors configured to communicate program instructions to a remote programming engine. The remote programming engine includes one or more processors configured to simulate operation of the implanted medical device based on the updated program instructions, and communicate updated program instructions to the implanted medical device based on the operation simulated.Type: GrantFiled: June 19, 2023Date of Patent: October 6, 2026Assignee: Pacesetter, Inc.Inventors: Suneela Joshi, Maobing Jin, Nidhi Narang, Voltaire Selverian, Pulkit Bisen, Chinsoo Kang
-
Patent number: 12746399Abstract: An implantable system includes an implantable medical device (IMD) and a non-transvenous lead that is configured to be implanted outside of a heart. The IMD includes an output configured to be connected at least to the lead, a current generator (CG) circuit configured to generate pacing pulses, a switching circuit coupled between the CG circuit and the output, one or more capacitors coupled in parallel with the CG circuit and the switching circuit, and a control circuit coupled to the CG circuit. The control circuit is configured to manage the CG circuit to generate the pacing pulses with a constant current at the output.Type: GrantFiled: March 5, 2024Date of Patent: September 29, 2026Assignee: Pacesetter, Inc.Inventors: Reza Shahandeh, Ninous Davoudi, Frank Lee, David Doudna, Jeffery Crook
-
Patent number: 12740750Abstract: Embodiments reduce burden associated with analyzing EGM segments obtained from an IMD that monitors for arrhythmic episodes. Respective EGM data and respective classification data is obtained for each arrhythmic episode detected by the IMD during a period of time. A representative R-R interval or HR for each of the arrhythmic episodes is determine by the IMD, wherein a manner for determining the representative R-R interval or HR depends on the type of the arrhythmic episode, such that for at least two different types of arrhythmic episodes the manners differ. An external system (ES) obtains data from the IMD, directly or indirectly, and selects arrhythmic episode(s) for which corresponding EGM segments are to be displayed for each type of arrhythmic episode, wherein the selecting is performed based on the representative R-R intervals or HRs determined by the IMD for the arrhythmic episodes. Additional and alternative embodiments are also described herein.Type: GrantFiled: November 26, 2024Date of Patent: September 22, 2026Assignee: Pacesetter, Inc.Inventors: Nima Badie, Fujian Qu, Leyla Sabet, Fady Dawoud, Kevin Davis, Christopher Gloschat, Aditya Goil, Mostafa Sadeghi
-
Patent number: 12733876Abstract: Described herein are methods, devices and systems for efficiently storing data for sensed biological signals. A sensed biological signal, or an amplitude and/or filtered version thereof, is provided to an N-bit ADC of an IMD to produce an N-bit data value indicative of an amplitude of the biological signal at a point in time. One of a plurality of chords of a compression curve is selected, based on a magnitude of the N-bit data value, and used to produce an M-bit data value, which is a compressed version of the N-bit data value, wherein M<N. The M-bit data value is stored as an M-bit data slice within memory of the IMD, and can be expanded to a reproduced N-bit data value after being uploaded to a non-implanted device or system.Type: GrantFiled: July 6, 2022Date of Patent: September 15, 2026Assignee: Pacesetter, Inc.Inventors: Dean Andersen, Xing Pei, David Doudna, Reza Shahandeh
-
Publication number: 20260263804Abstract: A computer implemented method and system is provided for managing neural stimulation therapy. The method comprises under control of one or more processors configured with program instructions. The method delivers a series of candidate stimulation waveforms having varied stimulation intensities to at least one electrode located proximate to nervous tissue of interest. A parameter defines the candidate stimulation waveforms is changed to vary the stimulation intensity. The method identifies a first candidate stimulation waveform that induces a paresthesia-abatement effect, while continuing to induce a select analgesic effect. The method further identifies a second candidate stimulation waveform that does not induce the select analgesic effect. The method sets a stimulation therapy based on the first and second candidate stimulation waveforms.Type: ApplicationFiled: April 29, 2026Publication date: September 10, 2026Applicant: Pacesetter, Inc.Inventors: Xiaoyi MIN, Alexander KENT, Richard WILLIAMSON
-
Patent number: 12727808Abstract: Computer implemented methods and implantable medical devices (IMD) are provided that obtain cardiac activity (CA) signals for a cardiac beat and compare the CA signals to a sensitivity level to detect a sensed event. One or more processors are configured to change the sensitivity level, utilized by the sensing circuitry, over the cardiac beat based on an adaptive sensitivity profile. The adaptive sensitivity profile has a maximum sensitivity limit (MSL). The process determines whether a characteristic of interest (COI) from a candidate event satisfies criteria relative to the COI for a collection of prior sensed events, declares the candidate event to be a valid sensed event or a false sensed event based on the determine operation; and adjusts the maximum sensitivity limit based on when the COI from the candidate event satisfies the criteria to provide adaptive sensing of CA signals.Type: GrantFiled: September 21, 2022Date of Patent: September 8, 2026Assignee: Pacesetter, Inc.Inventors: Jan O. Mangual-Soto, Nima Badie, Wenwen Li, Fady Dawoud
-
Publication number: 20260249087Abstract: Leadless pacemakers (LPs) and methods and systems for use therewith are disclosed. During a first period of time, during which an LP receives event messages from a second LP, the LP times its pacing of a first cardiac chamber based on the event messages received from the second LP so that AV synchrony is maintained, and the LP determines and stores count value(s). Based on at least one of the count value(s), the LP determines a compensation offset indicative of a drift between timing circuitry of the LP and timing circuitry of the second LP. During a second period of time, during which the LP does not receive event messages from the second LP, the LP times its pacing of the first cardiac chamber based on the compensation offset to thereby compensate for the drift so that the AV synchrony is also maintained during the second period of time.Type: ApplicationFiled: February 12, 2026Publication date: August 27, 2026Applicant: Pacesetter, Inc.Inventors: Xiyao Xin, Shiloh Sison, Xi Lin Chen
-
Publication number: 20260249083Abstract: Leadless pacemakers (LPs) and methods and systems for use therewith are disclosed that are specifically for use with a multi (e.g., dual) chamber LP system that performs AAI+VVI operation. More specifically, an atrial LP (aLP) and a ventricular LP (vLP) collectively provide the AAI+VVI operation. Additionally, at least one of the aLP or the vLP determines a compensation offset and uses the compensation offset to compensate for drift between timing circuitry of the atrial LP and timing circuitry of the vLP while the aLP and the vLP are providing for AAI+VVI operation, so that synchronization between atrial and ventricular pacing is maintained whenever the vLP delivers ventricular pacing during two or more consecutive cardiac cycles during the AAI+VVI operation.Type: ApplicationFiled: February 12, 2026Publication date: August 27, 2026Applicant: Pacesetter, Inc.Inventors: Xiyao Xin, Shiloh Sison, Xi Lin Chen
-
Patent number: 12714863Abstract: An implantable lead includes an inner lead subassembly contained within and movable relative to an outer lead subassembly. The inner lead subassembly has a helical electrode to pace a target anatomy. The outer lead subassembly includes a ring electrode to sense or pace the target anatomy. A threaded interface interconnects the inner lead subassembly and the outer lead subassembly such that relative rotation of the lead subassemblies causes relative axial movement between the helical electrode and the ring electrode. Other embodiments are also described and claimed.Type: GrantFiled: December 6, 2023Date of Patent: August 25, 2026Assignee: Pacesetter, Inc.Inventors: Steve Chantasirivisal, Keith Victorine, Wesley Alleman, Robert Shaw
-
Patent number: 12714870Abstract: The present disclosure provides systems and methods for applying anti-tachycardia pacing (ATP) using subcutaneous implantable cardioverter-defibrillators (SICDs). An SICD implantable in a subject includes a case including a controller, and at least one conductive lead extending from the case. The at least one conductive lead includes a plurality of coil electrodes, wherein the SICD is configured, via the controller, to apply anti-tachycardia pacing (ATP) to the subject using the at least one conductive lead.Type: GrantFiled: March 1, 2024Date of Patent: August 25, 2026Assignee: Pacesetter, Inc.Inventors: Gene A. Bornzin, Xiaoyi Min, Wenwen Li, Stuart Rosenberg, Kyungmoo Ryu, Alexander R. Bornzin, Leyla Sabet, Shubha Asopa, Xing Pei
-
Patent number: 12714463Abstract: A loading tool for loading a biostimulator onto a biostimulator delivery system is described. The loading tool includes a first body portion and a second body portion connected by a hinge. A latch is mounted on the first body portion, and the latch can be locked to fasten the first body portion to the second body portion. A biostimulator can be mounted in the loading tool, and a tether of a biostimulator delivery system can be inserted through a funnel in the loading tool to engage the biostimulator. An operator can use only one hand to unlock the latch, open the loading tool, and remove the loading tool from the biostimulator prior to delivering the biostimulator into a patient. Other embodiments are also described and claimed.Type: GrantFiled: July 30, 2024Date of Patent: August 25, 2026Assignee: Pacesetter, Inc.Inventors: Byron Liehwah Chun, Sondra Orts, Thomas B. Eby, Stephanie M. Raymond, Mike Sacha, Bernhard Arnar, Adam Weber, Jennifer Heisel, Wade Keller
-
Patent number: 12708782Abstract: Implementations described and claimed herein provide systems and methods for delivering and retrieving a leadless pacemaker. In one implementation, a leadless pacemaker has a docking end, and the docking end has a docking projection extending from a surface. A docking cap has a body defining a chamber. A retriever has sheaths extending with lumens distally from the chamber. A snare extends between the lumens forming a first snare loop pointing in a first direction and a second snare loop pointing in a second direction with a docking space formed therebetween. The snare is movable between an engaged position and a disengaged position by translating the first snare wire and the second snare wire within the first snare lumen and the second snare lumen. The engaged position includes the first snare wire and the second snare wire tightened around the docking projection within the docking space.Type: GrantFiled: July 1, 2024Date of Patent: August 18, 2026Assignee: Pacesetter, Inc.Inventors: Arundhati Kabe, Thomas B. Eby
-
Publication number: 20260224168Abstract: Disclosed herein is an implantable medical device (IMD), system and method for denoising biological signals. The IMD generates a biological signal representative of a physiologic parameter of a patient and normally analyzes the biological signal to detect a characteristic of interest (COI) indicative of a pathophysiologic condition of the patient. The present technology denoises, when the IMD is exposed to a noise causing condition, noisy biological signal segments of the biological signal generated while the IMD is exposed to the noise causing condition using a denoising prediction model to obtain denoised biological signal segments. The denoising prediction model is trained to predict a denoised biological signal segment from a noisy biological signal segment. The denoised biological signal segments can then be analyzed to detect the COI indicative of the pathophysiologic condition of the patient.Type: ApplicationFiled: January 21, 2026Publication date: August 6, 2026Applicant: Pacesetter, Inc.Inventors: Ruoli Jiang, Shiloh Sison
-
Publication number: 20260224903Abstract: Described herein is a multi-chamber implantable LP system comprising at least a first LP configured to be implanted in or on a first cardiac chamber, and a second LP configured to be implanted in or on a second cardiac chamber. For each cardiac event, of a plurality of cardiac events associated with the first cardiac chamber, the first LP is configured to determine for the cardiac event whether at least one of a plurality of predetermined conditions is satisfied. Additionally, the first LP is configured to abstain from transmitting a cardiac event message indicative of the cardiac event to the second LP, or transmit the cardiac event message indicative of the cardiac event to the second LP, based on whether there is a determination that at least one of the plurality of predetermined conditions is satisfied. Methods for use with such a multi-chamber implantable LP system are also described herein.Type: ApplicationFiled: January 13, 2026Publication date: August 6, 2026Applicant: Pacesetter, Inc.Inventors: Matthew G. Fishler, Weiqun Yang